What is the current Animal Model for Testing market size?

The Animal Model for Testing market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Animal Model for Testing market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Animal Model for Testing market?

Key drivers include rising research and development activities and growing adoption of animal models.

What are the major challenges facing the Animal Model for Testing market?

Challenges include high costs, ethical concerns, and regulatory complexities.

Which regions are leading the Animal Model for Testing market?

North America and Europe are currently leading the market due to strong research infrastructure.

Who are the top companies in the Animal Model for Testing market?

Top companies include Charles River, LabCorp, and Envigo, offering a range of animal models.

What future opportunities exist in the Animal Model for Testing market?

Future opportunities include emerging markets, innovative models, and personalized medicine applications.

How is technology impacting the Animal Model for Testing market?

Technology is enhancing model development, improving data analysis, and increasing testing efficiency.

What is the current regulatory landscape for the Animal Model for Testing market?

The regulatory landscape is complex, with varying laws and guidelines across regions and countries.

What is the future outlook for the Animal Model for Testing market?

The future outlook is positive, driven by growing demand and advancements in technology and models.

Animal Model for Testing Growth Drivers & Forecast Analysis 2033

Animal Model for Testing by Application (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies), by Types (Rats, Mice, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Animal Model for Testing Market Size | CAGR 7.8 Forecast 2033

Animal Model for Testing Growth Drivers & Forecast Analysis 2033

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Animal Model for Testing Market Overview

The Animal Model for Testing market refers to the use of living organisms, such as mice, rats, and non-human primates, to test the safety and efficacy of new drugs, chemicals, and other products. As the Animal Model for Testing market size is estimated to be around $1.4 billion in 2025, the growth outlook and market forecast indicate a significant expansion of the industry. The Animal Model for Testing market is expected to grow at a CAGR of 7.5% during the forecast period, driven by increasing demand for personalized medicine, advancements in gene editing technologies, and rising focus on regulatory compliance. Key forces shaping the industry include technology shifts towards more human-relevant models, regulatory requirements for animal welfare, and consumer behavior demanding more ethical testing methods.

Loading chart…

The largest region in the Animal Model for Testing market is North America, accounting for over 40% of the global market share, while the fastest-growing region is Asia-Pacific, driven by increasing investments in biomedical research and technological advancements. The growth of the Animal Model for Testing industry is driven by the need for more accurate and reliable testing methods, competitive intensity among pharmaceutical and biotechnology companies, and supply-chain dynamics that require efficient and cost-effective testing solutions. As the market continues to evolve, it is essential to stay informed about the latest trends, market forecast, and industry expansion to make strategic decisions and stay ahead of the competition.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	23.34 million
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Charles River Laboratories; Envigo; Taconic Biosciences; Jackson Laboratory; Crown Bioscience; JANVIER LABS; Shanghai SLAC; Shangghai Modelorg; GenOway; Syngene International; Psychogenics; Pharmaron; Pharmalegacy; Vitalstar Biotechnology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Animal Model for Testing market is poised for significant growth, driven by increasing demand for innovative treatments and therapies. The Animal Model for Testing market size is expected to expand substantially, with a growth forecast that underscores the sector's potential for investment and development.

Growth Drivers2 items

Advances in genetic engineering and gene editing technologies have enabled the creation of sophisticated animal models, enhancing the accuracy and reliability of testing outcomes, and thereby driving the Animal Model for Testing market forward.

The rising incidence of chronic diseases, such as cancer and neurological disorders, has led to an increased focus on developing effective treatments, further fueling the growth of the Animal Model for Testing market.

Restraints2 items

Stringent regulatory requirements and ethical concerns surrounding animal testing have led to increased costs and complexities for market participants, potentially hindering the growth of the Animal Model for Testing market size.

High operational costs associated with maintaining and breeding animal models can be a significant barrier to entry for new market entrants, limiting the potential for growth in the Animal Model for Testing market.

Opportunities2 items

The increasing adoption of personalized medicine and targeted therapies has created new opportunities for the development of specialized animal models, driving innovation and growth in the Animal Model for Testing market.

Emerging markets and developing economies present untapped opportunities for the expansion of the Animal Model for Testing market, driven by growing demand for biomedical research and development.

Challenges2 items

The need for standardization and harmonization of animal model testing protocols and methodologies poses a significant challenge for market participants, as it requires significant investment and collaboration.

Ensuring the welfare and well-being of animals used in testing is a critical challenge, as it requires careful balancing of scientific objectives with ethical considerations, and can impact the growth forecast of the Animal Model for Testing market.

Market Segmentation

Loading chart…

The Application segment in the Animal Model for Testing market refers to the various uses of animal models in research and development. This segment includes subtypes such as basic research, preclinical research, and toxicology testing. Each subtype contributes to the overall market size, with basic research being the largest contributor. The application segment is crucial in understanding the Animal Model for Testing segmentation, as it helps identify the key areas where animal models are being utilized. This information can be used to analyze market trends and predict future growth.

The Types segment in the Animal Model for Testing market comprises various species of animals used for testing, including mice, rats, and non-human primates. This segment is further divided into subtypes such as inbred animals, outbred animals, and transgenic animals. Each subtype has its own unique characteristics and advantages, contributing to the overall market size. Understanding the types of animal models used is essential for market taxonomy, as it helps researchers and manufacturers identify the most suitable models for their specific needs. The Animal Model for Testing market size is significantly influenced by the types of animal models used, making this segment a critical area of study.

Animal Model for Testing Segmentation Breakdown7 items

Application

Academic and Research Institutes

Pharmaceutical and Biotechnology Companies

Types

Rats

Mice

Others

Regional Insights

Loading chart…

The Animal Model for Testing market growth is expected to vary across regions, with North America holding the largest share, driven by key factors such as adoption of advanced technologies, policies supporting research and development, and significant investments in life sciences. The region's demographics and infrastructure also contribute to its dominance, with a large pool of skilled professionals and well-established research institutions.

The Asia Pacific region is expected to be the fastest-growing, driven by ecosystem maturity, increasing adoption of animal models, and supportive policies. The region's large and growing population, combined with its rapidly developing infrastructure, also contribute to its growth potential. In contrast, Europe's growth is driven by its mature ecosystem, high adoption rates, and significant investments in research and development.

Latin America and Middle East & Africa are expected to experience moderate growth, driven by increasing adoption and investments in research and development. However, these regions face challenges such as limited infrastructure and ecosystem maturity, which may hinder their growth. Overall, the regional forecast for the Animal Model for Testing market indicates varying levels of growth across regions, with North America and Asia Pacific leading the way.

Competitive Landscape

The Animal Model for Testing market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, and product innovation. The Animal Model for Testing competitive landscape is characterized by key competitive levers including certifications, regulatory approvals, and strategic partnerships. Global players dominate the market, but local companies are also gaining traction, particularly in emerging economies.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies must focus on strategic initiatives that drive growth and sustainability.

Charles River Laboratories: regional expansion

Envigo: vertical integration

Taconic Biosciences: premium pricing

Jackson Laboratory: innovation pipeline

Crown Bioscience: local manufacturing

JANVIER LABS: OEM tie-ups

Key Animal Model for Testing Companies14 items

Charles River Laboratories

Envigo

Taconic Biosciences

Jackson Laboratory

Crown Bioscience

JANVIER LABS

Shanghai SLAC

Shangghai Modelorg

GenOway

Syngene International

Psychogenics

Pharmaron

Pharmalegacy

Vitalstar Biotechnology

Market Ecosystem

The Animal Model for Testing ecosystem encompasses a complex network of participants, spanning from upstream technology providers to downstream end users. This ecosystem can be broadly segmented into three primary tiers: upstream suppliers of raw materials and technologies, midstream integrators and manufacturers, and downstream channels and end users. Value is created and captured through the development, production, and application of animal models for testing, with each participant playing a distinct role in the overall value chain analysis.

Raw material suppliers — providing biological materials

Technology providers — developing testing technologies

OEMs/manufacturers — producing testing equipment

System integrators/EPCs — integrating testing systems

Distributors/channel partners — supplying testing models

End users/buyers — utilizing animal models for testing

Regulators/standards bodies — setting testing standards

The flow of value within the Animal Model for Testing ecosystem is influenced by control points, such as regulatory bodies and technology providers, which can impact adoption rates and standards. Dependency risks, including input constraints and approvals, can also affect the ecosystem. Furthermore, switching costs, partnerships, and interoperability requirements can create barriers to entry or exit. The ecosystem's dynamics can differ by region, with varying regulatory environments and market demands shaping the value chain and influencing participant interactions.

Recent Industry Insights

The Animal Model for Testing industry has witnessed significant developments over the last 12-18 months, with a notable shift in Animal Model for Testing industry trends. Recent partnerships between key players have led to the creation of innovative testing models, enhancing the accuracy and efficiency of research studies. Additionally, there have been several mergers and acquisitions, resulting in the consolidation of resources and expertise.

Furthermore, the launch of new products and technologies has expanded the capabilities of animal models, allowing for more precise and reliable testing. Regulatory changes have also played a crucial role, with updates to guidelines and standards driving the adoption of more humane and sustainable testing practices. These developments have been supported by funding rounds and expansions, enabling companies to invest in research and development and drive growth in the industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Animal Model for Testing market. The market attractiveness is moderate, driven by increasing demand for innovative therapies and treatments. The competitive intensity is high, with key players investing heavily in research and development. The long-term Animal Model for Testing market outlook is positive, with a growing need for effective testing models. The innovation landscape is rapidly evolving, with advancements in gene editing and in silico modeling. However, the demand–supply balance is a concern, with a shortage of skilled professionals and high operational costs. Key risk factors include regulatory changes and ethical concerns.

11 items

1. Executive Summary

2. Animal Model for Testing Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Animal Model for Testing Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Animal Model for Testing Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Academic and Research Institutes

6.1.2. Pharmaceutical and Biotechnology Companies

6.2. Global Animal Model for Testing Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Rats

6.2.2. Mice

6.2.3. Others

6.3. Global Animal Model for Testing Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Animal Model for Testing Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Animal Model for Testing Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Animal Model for Testing Market Competition by Key Manufacturers

8.1. Global Animal Model for Testing Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Animal Model for Testing: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Charles River Laboratories

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Envigo

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Taconic Biosciences

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Jackson Laboratory

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Crown Bioscience

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. JANVIER LABS

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Shanghai SLAC

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Shangghai Modelorg

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. GenOway

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Syngene International

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Psychogenics

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Pharmaron

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Pharmalegacy

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Vitalstar Biotechnology

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Animal Model for Testing Market

Figure 4: Global Animal Model for Testing Market: Drivers

Figure 5: Global Animal Model for Testing Market: Challenges

Figure 6: Global Animal Model for Testing Market: Trends

Figure 7: Global Animal Model for Testing Market: Opportunity

Figure 8: Global Animal Model for Testing Market: Restraint

Figure 9: Global Animal Model for Testing Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Animal Model for Testing Market Value (USD Million) By Region

Figure 15: Global Animal Model for Testing Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Animal Model for Testing Market Value (USD Million) By Region

Figure 23: Global Animal Model for Testing Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

81 items

Table 1: Market Segmentation Analysis

Table 2: Global Animal Model for Testing Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Animal Model for Testing Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Animal Model for Testing Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Animal Model for Testing Market Value (USD Million) By Region

Table 10: Global Animal Model for Testing Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Animal Model for Testing Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Animal Model for Testing Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Animal Model for Testing Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Charles River Laboratories Basic Information And Sales Area

Table 31: Charles River Laboratories. Products Portfolio

Table 32: Envigo Basic Information And Sales Area

Table 33: Envigo. Products Portfolio

Table 34: Taconic Biosciences Basic Information And Sales Area

Table 35: Taconic Biosciences. Products Portfolio

Table 36: Jackson Laboratory Basic Information And Sales Area

Table 37: Jackson Laboratory. Products Portfolio

Table 38: Crown Bioscience Basic Information And Sales Area

Table 39: Crown Bioscience. Products Portfolio

Table 40: JANVIER LABS Basic Information And Sales Area

Table 41: JANVIER LABS. Products Portfolio

Table 42: Shanghai SLAC Basic Information And Sales Area

Table 43: Shanghai SLAC. Products Portfolio

Table 44: Shangghai Modelorg Basic Information And Sales Area

Table 45: Shangghai Modelorg. Products Portfolio

Table 46: GenOway Basic Information And Sales Area

Table 47: GenOway. Products Portfolio

Table 48: Syngene International Basic Information And Sales Area

Table 49: Syngene International. Products Portfolio

Table 50: Psychogenics Basic Information And Sales Area

Table 51: Psychogenics. Products Portfolio

Table 52: Pharmaron Basic Information And Sales Area

Table 53: Pharmaron. Products Portfolio

Table 54: Pharmalegacy Basic Information And Sales Area

Table 55: Pharmalegacy. Products Portfolio

Table 56: Vitalstar Biotechnology Basic Information And Sales Area

Table 57: Vitalstar Biotechnology. Products Portfolio

Table 58: Global Market Value (USD Million) (2025-2032) By Application

Table 59: Global Market Share (%) By Application (2032)

Table 60: Global Market Value (USD Million) (2025-2032) By Types

Table 61: Global Market Share (%) By Types (2032)

Table 62: Global Animal Model for Testing Market Value (USD Million) By Region

Table 63: Global Animal Model for Testing Market Share (%) By Region (2025-2032)

Table 64: North America Market Value (USD Million) (2025-2032) By Country

Table 65: North America Market Value (USD Million) (2025-2032) By Application

Table 66: North America Market Value (USD Million) (2025-2032) By Types

Table 67: Europe Market Value (USD Million) (2025-2032) By Country

Table 68: Europe Market Value (USD Million) (2025-2032) By Application

Table 69: Europe Market Value (USD Million) (2025-2032) By Types

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 71: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 73: South America Market Value (USD Million) (2025-2032) By Country

Table 74: South America Market Value (USD Million) (2025-2032) By Application

Table 75: South America Market Value (USD Million) (2025-2032) By Types

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 77: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 79: Research Programs/Design For This Report

Table 80: Key Data Information From Secondary Sources

Table 81: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Animal Model for Testing Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	23.34 million
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Charles River Laboratories; Envigo; Taconic Biosciences; Jackson Laboratory; Crown Bioscience; JANVIER LABS; Shanghai SLAC; Shangghai Modelorg; GenOway; Syngene International; Psychogenics; Pharmaron; Pharmalegacy; Vitalstar Biotechnology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options